▪ Abstract Multiple sclerosis (MS) develops in young adults with a complex predisposing
genetic trait and probably requires an inciting environmental insult such as a viral infection …

Multiple sclerosis (MS) is a prevalent inflammatory disease of the central nervous system
that often leads to disability in young adults. Treatment options are limited and often only …

Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand
(Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF …

Objective Many patients with multiple sclerosis (MS) are currently receiving treatment with
interferon (IFN)–β. Early identification of nonresponder patients is crucial to try different …

Multiple sclerosis is a complex disease, as several pathophysiological processes (including
inflammation, demyelination, axonal damage and repair mechanisms) participate in the …

Alzheimer's disease (AD) is the most common form of dementia, characterized by
progressive degeneration and loss of neurons in specific regions of the central nervous …

IFN‐β is effective in reducing relapses and magnetic resonance imaging (MRI) lesions in
multiple sclerosis (MS). It is assumed that individual therapeutic responses vary, but …

The expression of tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL)
and TRAIL receptors was investigated in resting and cytokine-activated purified primary …

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the
TNF superfamily and has been shown to induce apoptosis in cancer cells but not normal …

Increasingly, inflammatory mediators are considered crucial to the onset and perpetuation of
tendinopathy. We sought evidence of interleukin 17A (IL-17A) expression in early human …